SCHEMBL480968

SCHEMBL480968

NC(=O)Cc1ncc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9114299 0.98 TBXAS1 (0.49)
Glutarate SCHEMBL28564870 0.88 TBXAS1 (0.62)
SCHEMBL8519473 0.83 TBXAS1 (0.50)
Imidazoleacetic Acid SCHEMBL360337 0.81
SCHEMBL1261468 0.81
SCHEMBL18985083 0.80 TBXAS1 (0.45)
SCHEMBL2787115 0.80 TBXAS1 (0.57)
SCHEMBL2648605 0.79
SCHEMBL3056452 0.79
SCHEMBL1259774 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111606888-B Pyrrole derivative and preparation method and application thereof 中国药科大学 2023-08-18 CN claimed
EP-2285375-A2 SPIROAZAINDOLES Merck Sharp & Dohme Corp. (US) 2011-02-23 EP claimed
EP-2170876-A2 PHARMACEUTICAL COMPOSITION FOR PREVENTINTION AND TREATMENT OF RESTENOSIS COMPRISING ISOXAZOLE DERIVATIVES SK Holdings Co., Ltd. (KR) 2010-04-07 EP claimed
WO-2009137291-A2 SPIROAZAINDOLES MERCK & CO., INC. (US) 2009-11-12 WO claimed
WO-2009005269-A2 PHARMACEUTICAL COMPOSITION FOR PREVENTINTION AND TREATMENT OF RESTENOSIS COMPRISING ISOXAZOLE DERIVATIVES SK HOLDINGS CO., LTD. (KR) 2009-01-08 WO claimed
EP-1971600-A1 ISOXAZOLE DERIVATIVES AND USE THEREOF SK Holdings Co., Ltd. (KR) 2008-09-24 EP claimed
WO-2007078113-A1 ISOXAZOLE DERIVATIVES AND USE THEREOF SK HOLDINGS CO., LTD. (KR) 2007-07-12 WO claimed
US-5512588-A ANTIULCER AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-30 US claimed
EP-0174136-A1 Derivatives of dihydro-1H-pyrrolo(1,2-c)imidazol-3,5-dione as cognition activators WARNER-LAMBERT COMPANY (US) 1986-03-12 EP claimed
US-4079136-A Imidazolylacetic acid amides, their production, antimycotic compositions comprising said compounds and their use as antimycotic agents BAYER AKTIENGESELLSCHAFT (DT) 1978-03-14 US claimed
US-4033964-A Imidazolylacetic acid amides, their production, antimycotic compositions comprising said compounds and their use as antimycotic agents BAYER AKTIENGESELLSCHAFT (DT) 1977-07-05 US claimed
US-4032636-A IMIDAZOLYLACETIC ACID AMIDES, THEIR PRODUCTION, ANTIMYCOTIC COMPOSITIONS COMPRISING SAID COMPOUNDS AND THEIR USE AS ANTIMYCOTIC AGENTS BAYER AKTIENGESELLSCHAFT (DT) 1977-06-28 US claimed
US-4024270-A Antimycotic compositions containing an imidazolylacetic acid amide or salt thereof as the active agent and the use thereof in the treatment of mycoses BAYER AKTIENGESELLSCHAFT (DT) 1977-05-17 US claimed
US-3993647-A ANTIMYCOTIC BAYER AKTIENGESELLSCHAFT (DT) 1976-11-23 US claimed
US-3950354-A ANTIMYCOTIC AGENTS BAYER AKTIENGESELLSCHAFT (DT) 1976-04-13 US claimed
CN-119731159-A SARS-CoV2 main proteinase inhibitor 吉利德科学公司 2025-03-28 CN disclosed
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 US disclosed
US-3993647-A ANTIMYCOTIC BAYER AKTIENGESELLSCHAFT (DT) 1976-11-23 US disclosed
US-3950354-A ANTIMYCOTIC AGENTS BAYER AKTIENGESELLSCHAFT (DT) 1976-04-13 US disclosed
US-3950354-A ANTIMYCOTIC AGENTS BAYER AKTIENGESELLSCHAFT (DT) 1976-04-13 US disclosed